Dysfunction of vascular contraction in diabetes has been reported; however, the mechanisms are poorly understood. In this study, calcium sensitization involving increases in contraction in streptozotocin-induced diabetic rat aorta was detected. We hypothesize that an alteration in the intracellular signalling system plays a role in the dysfunction of vascular contractility in diabetes. Therefore, diacylglycerol (DG) kinase as a key enzyme of phosphatidylinositol (PI) turnover was investigated. Treatment with norepinephrine (NE) caused time- and dose-dependent activation of DG kinase in control rats. This activation required simultaneous increases in intracellular calcium concentration ([Ca2+]i) and protein kinase C (PKC) activation. In diabetic rats, hyper-reactivity of DG kinase involving inactivation in the resting state and over-activation in NE stimulation was observed. During hyper-reactivity, [Ca2+]i dependency of DG kinase was enhanced. Treatment with 50 mM KCl induced significant escalation in activity; moreover, basal activation of PKC was detected only in diabetes. These results suggested that PKC had been activated in the resting state. In contrast, these conditions were insufficient for DG kinase activation due to the absence of [Ca2+]i elevation. During NE-stimulation, PKC activation was maintained and [Ca2+]i increased. Therefore, DG kinase was activated and an elevation in calcium dependency enhanced this activation. The present study suggested that DG kinase hyper-reactivity in diabetes involved both an increase in [Ca2+]i and basal activation of PKC. This phenomenon may be associated with increased vascular contraction in diabetes mediated by acceleration of PI-turnover. Keywords: Vascular smooth muscle, insulin-dependent diabetes mellitus, norepinephrine, phosphatidylinositol-turnover, calcium, contraction, protein kinase C Introduction Insulin-dependent diabetes mellitus (IDDM) results as a consequence of decreased insulin secretion and/or desensitization of insulin receptors, leading to complicating dysfunctions in many types of tissue (Ozturk et al., 1996). Diabetic patients appear to be particularly prone to disorders of the neurological, cardiovascular, gastrointestinal and reproductive systems (Raccah, 1998). It has been suggested that these complications are due to abnormalities in the nervous system. Recently, correlations between changes in intracellular signalling pathways and complications in many cell types have also been demonstrated (Ozturk et al., 1996; Schmidt et al., 1999). Clarification of this relationship may provide new information regarding the development of a treatment for diabetes. Phosphatidylinositol turnover (PI-turnover) occurs in numerous cell types; moreover, this process is involved in the intracellular signalling pathway. Changes in PI-turnover activity are believed to influence cellular functions. In PI-turnover, diacylglycerol (DG) plays an important role in cellular function as an endogenous activator of protein kinase C (PKC). Diacylglycerol kinase (DG kinase) phosphorylates DG, generating phosphatidic acid (PA) (Flores et al., 1996). Consequently, endogenous DG levels can be altered by DG kinase activity. We previously found that the carbachol (CCh)-induced muscarinic receptor mediated DG kinase activation in guinea-pig taenia coli (Nobe et al., 1994). Furthermore, we examined the mechanisms of regulation of DG kinase activation and discovered that both an increase in intracellular calcium concentration ([Ca2+]i) and PKC activation were required (Nobe et al., 1995; 1997). These observations suggested that regulation of DG kinase by PKC was an important feedback mechanism in PI-turnover. On the basis of these data, alterations in DG kinase activity in some tissues isolated from streptozotocin (STZ)-induced diabetic rats were detected (Nobe et al., 1998). In that investigation, DG kinase activity in diabetic aortic smooth muscle indicated marked changes. However, the mechanism(s) has not been clarified. The objective of this study was to clarify the mechanism(s) of DG kinase activity change in diabetic rat aorta in order to understand the relation between alterations in the intracellular signalling pathway and dysfunctions in vascular smooth muscle contractility. The present findings suggest that both increases in DG kinase calcium dependency and basal activation of PKC are involved in the hyper-reactivity of DG kinase, which may lead to enhancement of aortic contractility in diabetes.